Here's something to throw in the pot to get some discussion...

Here's something to throw in the pot to get some discussion going:
Its stated that 100 people have signed up for CannEpil expected to generate $1 mil in sales
The market in Australia alone is 70000 potential customers which suggests that at the extreme, assuming everyone will be paying $800pa then revenue from this alone would be around $56mil. Using a generous 25% margin would provide an EBIT of around $14 mil which equates roughly to 1.1cps. That gives a multiple of 8.45 times earnings based on a current price of 9.3cps

Based on the fact that CannEpil could have a global reach and that MXC has the Varm Cosmo deal and now plus the Mabsut deal and goodness knows how many other deals they are leading, these shares are severely undervalued. At a PE of 20 times, far more realistic for a growth stock, the SP should be more like 22c and above.